Title:
【発明の名称】アレルギーおよび炎症疾患の治療用化合物
Document Type and Number:
Japanese Patent JP2873090
Kind Code:
B2
Abstract:
Novel compounds of Formula (I) are described herein. These compounds inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production. The compounds of the present invention are also useful in the mediation or inhibition of enzymatic or catalytic activity of phosphodiesterase IV and are therefore useful in the treatment of disease states in need of mediation or inhibition thereof.
More Like This:
| JP6228230 | Fluoridation CBD compounds, those constituents, and use |
| WO/1994/019008 | COMBINATIONS OF RETROVIRAL INHIBITORS |
| JPS5967213 | COSMETIC COMPOSITION |
Inventors:
KURISUTENSEN JIIKUFURIITO BII ZA FUOOSU
Application Number:
JP51744693A
Publication Date:
March 24, 1999
Filing Date:
March 05, 1993
Export Citation:
Assignee:
SUMISUKURAIN BIICHAMU CORP
International Classes:
A61K31/215; A61K31/275; A61K31/41; A61K31/42; A61K31/4245; A61K31/425; A61K31/433; A61P11/00; A61P29/00; A61P35/00; A61P37/00; A61P37/08; A61P43/00; C07C43/205; C07C43/225; C07C43/23; C07C61/28; C07C69/003; C07C69/712; C07C69/75; C07C69/753; C07C237/30; C07C255/46; C07C259/06; C07C259/08; C07C303/30; C07C311/15; C07C319/12; C07C323/60; C07D257/04; C07D271/06; C07D271/10; C07D285/12; C07C309/65; (IPC1-7): C07C255/46; A61K31/275; A61K31/41; C07D257/04; C07D271/06; C07D271/10; C07D285/12
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)